Explosive Growth Expected: Recombinant Proteins Market to Expand at 7.4% CAGR Through 2030
2024: Merck KGaA has announced a substantial investment of over USD 320.8 million in a new Life Science Research Center at its global headquarters in Darmstadt, Germany.
According to MarkNtel Advisors study, The Global Recombinant Proteins Market size is estimated to grow at a CAGR of around 7.4% during the forecast period, i.e., 2024-30.
In recent years, there has been a surge in patients suffering from cystic fibrosis and other Recombinant proteins are generally developed using specialized machines & equipment, which are expensive. Additionally, the raw materials used during the production phase are also limited & relatively of higher costs. Therefore, the market players often sell the recombinant proteins at higher costs to earn profits. Hence, small laboratories & small diagnostics facilities refrain from opting for these solutions, impeding Global Recombinant Proteins Market Growth.
Moreover, these recombinant proteins are highly used in the healthcare sector & R&D facilities. Therefore, these products are supposed to adhere to the safety standards imposed by the global governing bodies. Compliance with these safety standards includes the usage of the other vital components during the production phase, which further puts a financial strain on the manufacturers. Therefore, to distribute their operational & raw material costs, the market players offer their products at relatively higher prices. Consequently, this is forcing the end-users to look for substitute solutions, hampering the Global Recombinant Proteins Market growth.
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Download Free Sample Copy @ https://www.marknteladvisors.com/query/request-sample/recombinant-proteins-market.html
Key Findings in Recombinant Proteins Market:
| Historical Years | 2019-2022 |
| Base Years | 2023 |
| Forecast Years | 2024-2030 |
| Key Report Highlights | · Market Dimensions & Projections· Pricing Evaluation,· Recent Strategic Moves by Companies,· Primary Stakeholders,· Analysis of Import and Export Trends,· Competitive Landscape Assessment,· Emerging Opportunities,· Market Trends and Indicators |
| Reports Delivery Format | Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address. |
Recombinant Proteins Market Key Players:
Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Abcam Limited, Novozymes A/S, GenScript Biotech Corporation, R&D Systems, Inc., ProSpec-Tany TechnoGene Ltd., Cell Signaling Technology, Inc., Enzo Life Sciences, Inc., Sino Biological Inc., Miltenyi Biotec, Abnova Corporation, RayBiotech, Inc., OriGene Technologies, Inc., Others
Market Segmentation Overview:
By Product
-Growth Factors and Cytokines
–Epidermal Growth Factor (EGF)
–Platelet-Derived Growth Factor (PDGF)
–Fibroblast Growth Factor (FGF)
–Interferons
–Interleukins
–Others (Vascular Endothelial Growth Factor (VEGF), Transforming Growth Factor-Beta (TGF-β), etc.)
-Antibodies
-Immune Checkpoint Proteins
-Structural Proteins
-Enzymes
–Kinases
–Hydrolase
–Others (Proteases, Lipases, etc.)
-Recombinant Regulatory Proteins
-Hormones
-Others (Membrane Proteins, Adhesion Molecules & Receptors, etc.)
By Host Cells
-Mammalian Cells
-Insect Cells
-Yeast & Fungi
-Bacterial Cells
-Others
By Application
-Therapeutics
–Biologics
–Vaccines
–Cell & Gene Therapies
–Others (Immunotherapy, Regenerative Medicine, etc.)
-Research & Development
-Diagnostics
-Biotechnology
-Others (Industrial, Cosmetics & Personal Care, etc.)
By End Users
-Pharmaceutical & Biopharmaceutical Companies
-Research Institutes and Academic Institutions
-Diagnostic Laboratories
-Others (Contract Research Organizations (CROs), Biotechnology Companies, etc.)
Of them all, Pharmaceutical & Biopharmaceutical Companies hold a noteworthy share in the Global Recombinant Proteins Market. Pharma & Bio-Pharma companies often run several clinical research & investigations to develop products with improved treatment results. This research includes the extensive utilization of recombinant proteins to enhance the product’s effectiveness. As a result, pharma & biopharmaceutical companies increasingly use recombinant proteins, amplifying the Global Recombinant Proteins Market growth. Additionally, these companies are investing heavily in developing products that enhance the treatment given to patients. Therefore, the production & development of these innovative therapeutic drugs would continue to fuel the demand for recombinant proteins, amplifying the market size in the forecast years as well.
Read Full Report @ https://www.marknteladvisors.com/research-library/recombinant-proteins-market.html
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
The Recombinant Proteins Industry Recent Development:
2024: GenScript Biotech Corporation recently unveiled its latest AI innovations, including GenSmart™ Codon Optimization, a free online tool enhancing gene sequence design for improved expression across various host organisms, particularly focusing on recombinant protein production.
Note: If you require specific information not covered in the current report, we can provide it through customized option
Explore Related Reports: –
About MarkNtel Advisors:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Being one of the most efficient market research companies in India, our specialized team of experienced & efficient market research professionals is capable of grasping every minute and valuable information & data of the market to offer our clients with satisfactory details. Our company has served the biggest market research firms in India at leading positions and is proficient in managing all types of market research projects.
Have an Any Query,
Call Us – US Office: +1 628 895 8081
Email – sales@marknteladvisors.com
Address Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India